COMMUNIQUÉS West-GlobeNewswire
-
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
12/10/2026 -
Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026
12/10/2026 -
NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness
12/10/2026 -
Kraig Labs Races to Scale Production as Billion-Dollar High-Performance Materials Market Starved for Scalable Supply Beckons
12/10/2026 -
AnewHealth and IntusCare Announce Advanced, Bidirectional Integration to Simplify Medication Management for PACE Programs
12/10/2026 -
SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum
12/10/2026 -
IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
12/10/2026 -
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin – IFIH1 siRNA Conjugate for the Treatment of Type 1 Diabetes
12/10/2026 -
Ozari Health Expands Nationwide GLP-1 Telehealth Platform With Two Plans for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
12/10/2026 -
Baylor Genetics to Showcase How Genome Sequencing is Advancing Pediatric Care at the 2026 Child Neurology Society Annual Meeting
12/10/2026 -
Waylo Ahead Launches Initiative for Young Drivers Beyond the Test
12/10/2026 -
Alignment Health Launches New Medicare Advantage Plan Designed for Asian American Seniors in Los Angeles and Orange Counties
12/10/2026 -
Transactions under Novonesis’ share buyback program
12/10/2026 -
MediciNova CEO Provides Shareholder Update
12/10/2026 -
Gates Foundation and Wellcome Leap Commit $100 Million to Reduce Global Stillbirth Rates
12/10/2026 -
BSACI 2026: New preference and ease-of-use data comparing EURneffy® nasal adrenaline spray and adrenaline auto-injector trainer devices
12/10/2026 -
Novo Nordisk A/S - share repurchase programme
12/10/2026 -
ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting
12/10/2026 -
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
12/10/2026
Pages